4.2185
Diamedica Therapeutics Inc 주식(DMAC)의 최신 뉴스
DiaMedica targets preeclampsia Phase 2 dose selection and ReMEDy2 interim analysis in H1 2026 as enrollment momentum builds - MSN
DiaMedica Therapeutics reports annual meeting results By Investing.com - Investing.com Canada
DiaMedica Therapeutics reports annual meeting results - Investing.com
DiaMedica Elects Directors at Annual Meeting - TipRanks
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2025 Earnings Call Transcript - Insider Monkey
DiaMedica Therapeutics Inc (DMAC) Q1 2025 Earnings Call Highlights: Strong Financial Position ... - Yahoo Finance
DiaMedica Therapeutics Reports Q1 2025 Financials and Trial Progress - TipRanks
DiaMedica Therapeutics Announces Poster Presentation at European - GuruFocus
DiaMedica Therapeutics Announces Poster Presentation At European Stroke Organisation ConferenceESOC 2025 - marketscreener.com
DiaMedica Therapeutics Announces Poster Presentation at European Stroke Organisation Conference – ESOC 2025 - Business Wire
Earnings call transcript: DiaMedica Therapeutics Q1 2025 earnings beat expectations By Investing.com - Investing.com India
Transcript : DiaMedica Therapeutics Inc., Q1 2025 Earnings Call, May 14, 2025 - marketscreener.com
Earnings call transcript: DiaMedica Therapeutics Q1 2025 earnings beat expectations - Investing.com Australia
Barclays PLC Takes Position in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World
Raymond James Financial Inc. Makes New Investment in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World
DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights - BioSpace
DiaMedica Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
DiaMedica Therapeutics Reports Q1 2025 Financial Results and Clinical Progress - TipRanks
DiaMedica (DMAC) Awaits Key Phase 2 Study Results for Preeclamps - GuruFocus
DiaMedica Therapeutics Reports First Quarter 2025 Financial Resu - GuruFocus
DiaMedica Therapeutics Q1 2025 Earnings Call Transcript - MarketBeat
Susquehanna International Group LLP Grows Holdings in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - The AM Reporter
DiaMedica Therapeutics to Participate in Upcoming Investor Conferences in May - BioSpace
How To Trade (DMAC) - news.stocktradersdaily.com
DiaMedica Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update May 14, 2025 - BioSpace
DiaMedica Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update May 14, 2025 | DMAC Stock News - GuruFocus
Bank of Montreal Can Buys New Stake in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
We're Hopeful That DiaMedica Therapeutics (NASDAQ:DMAC) Will Use Its Cash Wisely - Yahoo Finance
LPL Financial LLC Buys 11,500 Shares of DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World
Financial Contrast: BioVie (NASDAQ:BIVI) vs. DiaMedica Therapeutics (NASDAQ:DMAC) - Defense World
DiaMedica Therapeutics: Stroke Developer With Low Cash Reserve (NASDAQ:DMAC) - Seeking Alpha
Raymond James Financial Inc. Purchases Shares of 15,267 DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World
(DMAC) Trading Report - news.stocktradersdaily.com
DiaMedica Therapeutics (NASDAQ:DMAC) Price Target Raised to $10.00 - Defense World
Equities Analysts Offer Predictions for DMAC Q1 Earnings - Defense World
DiaMedica Therapeutics Reports 2024 Financial Results - TipRanks
DiaMedica Therapeutics Announces Closing of $8.5 Million Public Offering of Common Shares - Business Wire
H.C. Wainwright lifts DiaMedica stock target to $10 on trial hopes - Investing.com Canada
H.C. Wainwright lifts DiaMedica stock target to $10 on trial hopes By Investing.com - Investing.com South Africa
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2024 Earnings Call Transcript - Insider Monkey
DiaMedica Therapeutics Inc (DMAC) Q4 2024 Earnings Call Highlights: Strong Financial Position ... - Yahoo
DiaMedica Therapeutics’ Optimistic Earnings Call Highlights - TipRanks
Earnings call transcript: DiaMedica Q4 2024 results and stock surge By Investing.com - Investing.com South Africa
Earnings call transcript: DiaMedica Q4 2024 results and stock surge - Investing.com India
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results - BioSpace
DiaMedica Therapeutics Reports 2024 Financial Results and Strategic Advancements - TipRanks
DiaMedica Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
DIAMEDICA THERAPEUTICS Earnings Results: $DMAC Reports Quarterly Earnings - Nasdaq
Insider Stock Buying Reaches US$9.00m On DiaMedica Therapeutics - Yahoo Finance
Where are the Opportunities in (DMAC) - Stock Traders Daily
DIAMEDICA THERAPEUTICS Earnings Preview: Recent $DMAC Insider Trading, Hedge Fund Activity, and More - Nasdaq
자본화:
|
볼륨(24시간):